catching up, expectation is doing work
Thread · #retatrutide · 2025-11-08
the triple agonist mechanism is well described
Spun off from a message in #retatrutide on 2025-11-08. 15 messages, 6 participants.
The message this came from
- thirty_one_g — the triple agonist mechanism is well described. what any individual feels is not attributable to a mechanism, i logged it either way 20:45
the honest summary is that the weight results in the published work were large and the safety picture is young, one persons data
energy expenditure isnt something i could feel, though my sleep tracker disagreed with me
independent purity testing is the one part of this where the room has anything solid, and it is worth paying for
lost 31kg over 21 months at doses well under what the trials used, not approved for human use
triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history, no label means no ladder
not recommending anything but this is research use material that is not approved for human use, and that is not a formality on this one
from eight months of rhr data my resting rate went up 7 bpm in the first month and came back most of the way by month 13
💀7
Janoshik came back 97.4 on one lot and 99.2 on the next from the same HJ, both fine, i would rather be careful than confident here
phase 2 doses are published and theyre not far off what people here run, coincidence rather than plan, happy to be pointed at better data
the strongest honest position in this channel is interested and cautious, and that has been the position since 2024, phase two is all we have
💀16
logging this properly, so nobody should be citing a chat channel as a source about this, including this one, not a clinician
holding low, reporting people insist on small steps because the side effects arrive faster than on the other two
and independent assays
the half life supports weekly dosing and thats what ive done from the start